Summary
Weight gain during adjuvant chemotherapy has been reported by several authors. Because increased body weight at diagnosis is associated with an increased risk of disease recurrence, we have assessed the prevalence of weight gain in a series of patients receiving adjuvant treatment, as well as the association of weight gain with type of treatment and risk of recurrence. We first assembled an inception cohort of 237 patients who had all undergone pretreatment evaluation and treatment at one institution, and had already been followed for at least 12 months. Body weight at the start and completion of treatment was recorded, as was type of treatment and status at last followup. Ninety-six percent of patients gained weight during treatment and none lost weight (mean increase 4.3 kg). Weight gain was strongly associated with treatment, and was least in patients receiving single agent chemotherapy, greatest in patients treated with ovarian ablation and prednisone, and intermediate in those receiving combination chemotherapy. There was no association between weight gain and disease recurrence.
References
Knobf MK, Mullen JC, Xistris D, Moritz DA: Weight gain in women with breast cancer receiving adjuvant chemotherapy. Oncology Nursing Forum 10:28–33, 1983
Dixon J, Moritz DA, Baker FL: Breast cancer and weight gain: An unexpected finding. Oncology Nursing Forum 5:5–7, 1978
Subramanian VP, Raich PC, Walker BK: Weight gain in breast cancer patients undergoing chemotherapy. Breast Cancer Res Treat 1:170, 1981 (Abstract)
Meyerowitz BE, Watkins K, Sparks FC: Quality of life for breast cancer patients receiving adjuvant chemotherapy. Am J Nursing 83:232–235, 1983
Donegan WL, Hartz AJ, Rimm AA: The association of body weight and recurrent cancer of the breast. Cancer 41:1590–1594, 1978
Boyd NF, Campbell JE, Germanson T, Thomson DB, Sutherland DJ, Meakin JW: Body weight and prognosis in breast cancer. J Natl Cancer Inst 67:785–789, 1981
Tarttner PE, Papatestas AE, Ioannovich J, Mulvihill MN, Lesnick G, Aufses AH: Cholesterol and obesity as prognostic factors in breast cancer. Cancer 47:2222–2227, 1981
Sumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holland J, Fukushima DK: Nonobesity at the time of mastectomy is highly predictive of 10 year disease free survival in women with breast cancer. Anticancer Res 2:59–62, 1982
Feinstein AR: Clinical biostatistics XI. Sources of ‘chronology bias’ in cohort statistics. Clin Pharmacol Ther 12:864–879, 1971
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1–39, 1977
Cox R: Regression models and life tables: J R Stat Soc (Series B) 34:187–220, 1972
Selby PJ, Campbell J, Etezadi-Amoli J, Boyd NF: The development of a method for assessing the quality of life of cancer patients. Br J Cancer 50:13–22, 1984
Rowland-Payne CME, Abbott M, Jone JM, Powles TJ, Coombes RC: Weight loss during therapy for advanced breast cancer. Clin Oncol 8:33–38, 1982
Maguire GP, Lee EG, Bevington DJ, Kuchemann CS, Crabtree RJ, Cornell CE: Psychiatric problems in the first year after mastectomy. Br Med J 1:963–965, 1978
Author information
Authors and Affiliations
Additional information
Supported in part by the Institute of Medical Sciences, University of Toronto, and the National Cancer Institute of Canada.
Rights and permissions
About this article
Cite this article
Heasman, K.Z., Sutherland, H.J., Campbell, J.A. et al. Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Tr 5, 195–200 (1985). https://doi.org/10.1007/BF01805994
Issue Date:
DOI: https://doi.org/10.1007/BF01805994